Eva Live, Inc.
GOAI
$4.10
$1.8380.62%
| Weiss Ratings | GOAI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | GOAI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | GOAI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.21 | |||
| Price History | GOAI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 2.50% | |||
| 30-Day Total Return | -8.48% | |||
| 60-Day Total Return | -21.15% | |||
| 90-Day Total Return | -41.43% | |||
| Year to Date Total Return | -39.35% | |||
| 1-Year Total Return | -65.49% | |||
| 2-Year Total Return | -66.94% | |||
| 3-Year Total Return | -74.38% | |||
| 5-Year Total Return | -9.13% | |||
| 52-Week High % Change | -81.51% | |||
| 52-Week Low % Change | 13.50% | |||
| Price | GOAI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $12.28 | |||
| 52-Week Low Price | $2.00 | |||
| 52-Week Low Price (Date) | Mar 27, 2025 | |||
| 52-Week High Price (Date) | Apr 25, 2024 | |||
| Valuation | GOAI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 71.14M | |||
| Enterprise Value | 71.00M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.41 | |||
| Earnings Per Share Growth | 1,416.85% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 8.18 | |||
| Price/Book (Q) | -354.69 | |||
| Enterprise Value/Revenue (TTM) | 8.20 | |||
| Price | $4.10 | |||
| Enterprise Value/EBITDA (TTM) | -5.72 | |||
| Enterprise Value/EBIT | -5.64 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | GOAI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 31.20M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | GOAI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 310 229 5981 | |||
| Address | The Plaza Los Angeles, CA 90067 | |||
| Website | evaxai.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | GOAI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -145.30% | |||
| Profit Margin | -145.56% | |||
| Management Effectiveness | GOAI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -252.59% | |||
| Return on Equity | -- | |||
| Income Statement | GOAI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 8.66M | |||
| Total Revenue (TTM) | 8.66M | |||
| Revenue Per Share | $0.28 | |||
| Gross Profit (TTM) | 2.83M | |||
| EBITDA (TTM) | -12.41M | |||
| EBIT (TTM) | -12.58M | |||
| Net Income (TTM) | -12.61M | |||
| Net Income Avl. to Common (TTM) | -12.61M | |||
| Total Revenue Growth (Q YOY) | 16.66% | |||
| Earnings Growth (Q YOY) | -1,228.47% | |||
| EPS Diluted (TTM) | -0.41 | |||
| EPS Diluted Growth (Q YOY) | -1,148.52% | |||
| Balance Sheet | GOAI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 849.30K | |||
| Cash Per Share (Q) | $0.03 | |||
| Total Current Assets (Q) | 2.64M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -199.30K | |||
| Current Ratio (Q) | 1.056 | |||
| Book Value Per Share (Q) | -$0.01 | |||
| Total Assets (Q) | 2.70M | |||
| Total Current Liabilities (Q) | 2.50M | |||
| Total Debt (Q) | 700.00K | |||
| Total Liabilities (Q) | 2.90M | |||
| Total Common Equity (Q) | -199.30K | |||
| Cash Flow | GOAI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 710.20K | |||
| Net Change in Cash (TTM) | 294.00K | |||
| Levered Free Cash Flow (TTM) | -1.19M | |||
| Cash from Operations (TTM) | -416.20K | |||
